Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by Vinny57on Dec 06, 2018 1:28am
176 Views
Post# 29073809

It's Ironic

It's IronicGrego and his cronies say the report came out FOR the Aphria shareholder/investor.  It was to show the shareholders that management used diluting shares (less than $1 per share) for the LATAM purchases. That is $1 per share if the whole purchase was worthless (which it isn't).  So by publishing this report, (and helping us shareholders), we have dropped from the teens to $5...........Gee Grego, thanks for the heads up.
Bullboard Posts